GB2143238A - A method for enzyme liberation from bacterial cells - Google Patents

A method for enzyme liberation from bacterial cells Download PDF

Info

Publication number
GB2143238A
GB2143238A GB08308903A GB8308903A GB2143238A GB 2143238 A GB2143238 A GB 2143238A GB 08308903 A GB08308903 A GB 08308903A GB 8308903 A GB8308903 A GB 8308903A GB 2143238 A GB2143238 A GB 2143238A
Authority
GB
United Kingdom
Prior art keywords
bacterial cells
cells
temperature
lysis
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08308903A
Other versions
GB8308903D0 (en
Inventor
Dr Anthony Stuart Breeze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB08308903A priority Critical patent/GB2143238A/en
Publication of GB8308903D0 publication Critical patent/GB8308903D0/en
Publication of GB2143238A publication Critical patent/GB2143238A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The use of a temperature sensitive prophage to procure the lysis of bacterial cells increases the yield of protein available by avoiding the use of harsh or vigorous physical and chemical treatments and by causing the lysis of all the cells in the culture. The lytic process is induced by raising the temperature of the culture to a point at which the prophage becomes unstable but which still allows bacterial metabolism to continue. The method can be applied not only to batch grown cells but also to cells grown in continuous culture.

Description

SPECIFICATION A novel method for enzyme liberation from bacterial cells Traditional methods for the rupture of bacterial cells suffer from the disadvantages that the cells must usually be concentrated and cell breakage is often incomplete so that enzyme yield is less than that theoretically possible.
The induction of lysogenic bacteria involves less (if any) cell concentration and there is 100% cell lysis so that enzyme yield can be much higher.
The introduction of a temperature sensitive bacteriophage, e.g. At1857 into a suitable strain of Escherichia coli makes it possible to bring about the induction of the bacteriophage and hence rupture of the bacterial cells by raising the temperature of incubation for a short period.
In a typical example, a lysogenic strain of E.
coli is cultured at 30"C to the appropriate point in the growth cycle for maximum enzyme production. The cells are harvested and resuspended in growth medium, re-incubated for approximately 1 hr at 30"C and then the temperature raised to 42"C for 30 mins followed by a further period of 2-3 hrs at 30"C to allow complete lysis of the cells and enzyme liberation.
The technique will be eminently suitable for application in a continous process whereby growing the cells at sufficient density would obviate the need for the harvesting/resuspension phase and allow direct induction on a continuous basis.
1. The use of a temperature sensitive prophage (or appropriate portion of the genome thereof) to procure the lysis of bacterial cells from within by raising the temperature of incubation, allowing the release of enzymes and other proteins into the suspending liquid.
2. The bacterial cells referred to in Claim 1 are grown in suitable culture medium until the most appropriate stage is reached for release of the desired enzyme or other protein.
3. The bacterial cells referred to in Claim 1 can be grown in continuous culture and being withdrawn continuously are subjected to a higher temperature for a suitable length of time to initiate lysis of the bacterial cells.
4. The bacterial cells referred to in Claim 3 as having been subjected to a higher temperature may be returned to a lower temperature to allow the development of lysis of the bacterial cells.
**WARNING** end of DESC field may overlap start of CLMS **.

Claims (4)

**WARNING** start of CLMS field may overlap end of DESC **. SPECIFICATION A novel method for enzyme liberation from bacterial cells Traditional methods for the rupture of bacterial cells suffer from the disadvantages that the cells must usually be concentrated and cell breakage is often incomplete so that enzyme yield is less than that theoretically possible. The induction of lysogenic bacteria involves less (if any) cell concentration and there is 100% cell lysis so that enzyme yield can be much higher. The introduction of a temperature sensitive bacteriophage, e.g. At1857 into a suitable strain of Escherichia coli makes it possible to bring about the induction of the bacteriophage and hence rupture of the bacterial cells by raising the temperature of incubation for a short period. In a typical example, a lysogenic strain of E. coli is cultured at 30"C to the appropriate point in the growth cycle for maximum enzyme production. The cells are harvested and resuspended in growth medium, re-incubated for approximately 1 hr at 30"C and then the temperature raised to 42"C for 30 mins followed by a further period of 2-3 hrs at 30"C to allow complete lysis of the cells and enzyme liberation. The technique will be eminently suitable for application in a continous process whereby growing the cells at sufficient density would obviate the need for the harvesting/resuspension phase and allow direct induction on a continuous basis. CLAIMS
1. The use of a temperature sensitive prophage (or appropriate portion of the genome thereof) to procure the lysis of bacterial cells from within by raising the temperature of incubation, allowing the release of enzymes and other proteins into the suspending liquid.
2. The bacterial cells referred to in Claim 1 are grown in suitable culture medium until the most appropriate stage is reached for release of the desired enzyme or other protein.
3. The bacterial cells referred to in Claim 1 can be grown in continuous culture and being withdrawn continuously are subjected to a higher temperature for a suitable length of time to initiate lysis of the bacterial cells.
4. The bacterial cells referred to in Claim 3 as having been subjected to a higher temperature may be returned to a lower temperature to allow the development of lysis of the bacterial cells.
GB08308903A 1983-03-31 1983-03-31 A method for enzyme liberation from bacterial cells Withdrawn GB2143238A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08308903A GB2143238A (en) 1983-03-31 1983-03-31 A method for enzyme liberation from bacterial cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08308903A GB2143238A (en) 1983-03-31 1983-03-31 A method for enzyme liberation from bacterial cells

Publications (2)

Publication Number Publication Date
GB8308903D0 GB8308903D0 (en) 1983-05-11
GB2143238A true GB2143238A (en) 1985-02-06

Family

ID=10540532

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08308903A Withdrawn GB2143238A (en) 1983-03-31 1983-03-31 A method for enzyme liberation from bacterial cells

Country Status (1)

Country Link
GB (1) GB2143238A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215533A2 (en) * 1985-01-18 1987-03-25 Applied Biosystems, Inc. A method of extracting nucleic acids from cells
WO1992001791A1 (en) * 1990-07-26 1992-02-06 Boehringer Mannheim Gmbh Method of preparation of vaccines, and the use of the vaccines thus prepared
WO2000071731A1 (en) * 1999-05-25 2000-11-30 Phage Biotechnology Corporation Phage-dependent super-production of biologically active protein and peptides
WO2002014468A2 (en) * 2000-08-15 2002-02-21 Phage Biotechnology Corporation Phage-dependent superproduction of biologically active protein and peptides
GB2373512A (en) * 2000-11-15 2002-09-25 Lattice Intellectual Property A method of killing bacteria

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215533A2 (en) * 1985-01-18 1987-03-25 Applied Biosystems, Inc. A method of extracting nucleic acids from cells
EP0215533A3 (en) * 1985-01-18 1988-06-22 Applied Biosystems, Inc. A method of extracting nucleic acids from cells
WO1992001791A1 (en) * 1990-07-26 1992-02-06 Boehringer Mannheim Gmbh Method of preparation of vaccines, and the use of the vaccines thus prepared
WO2000071731A1 (en) * 1999-05-25 2000-11-30 Phage Biotechnology Corporation Phage-dependent super-production of biologically active protein and peptides
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
US6794162B2 (en) 1999-05-25 2004-09-21 Phage Biotechnology Corporation Phage-dependent super-production of biologically active protein and peptides
WO2002014468A2 (en) * 2000-08-15 2002-02-21 Phage Biotechnology Corporation Phage-dependent superproduction of biologically active protein and peptides
WO2002014468A3 (en) * 2000-08-15 2002-05-10 Phage Biotechnology Corp Phage-dependent superproduction of biologically active protein and peptides
US6773899B2 (en) 2000-08-15 2004-08-10 Phage Biotechnology Corporation Phage-dependent superproduction of biologically active protein and peptides
KR100761486B1 (en) * 2000-08-15 2007-10-04 카디오배스큘러 바이오 떼러퓨틱스, 인크. Phage-Dependent Superproduction of Biologically Active Protein and Peptides
GB2373512A (en) * 2000-11-15 2002-09-25 Lattice Intellectual Property A method of killing bacteria

Also Published As

Publication number Publication date
GB8308903D0 (en) 1983-05-11

Similar Documents

Publication Publication Date Title
US4237224A (en) Process for producing biologically functional molecular chimeras
US4468464A (en) Biologically functional molecular chimeras
ES8602124A1 (en) Externalization of products of bacteria.
US4652525A (en) Recombinant bacterial plasmids containing the coding sequences of insulin genes
BR8807408A (en) PROCESS FOR CONTINUOUS FERMENTATION OF MEDIA CONTAINING CARBON HYDRATE WITH BACTERIAL ASSISTANCE
GB2143238A (en) A method for enzyme liberation from bacterial cells
DE3681738D1 (en)
MX172984B (en) IMMUNO-STIMULATING AGENT
US4403035A (en) In vitro DNA-Protein viral assembly and gene cloning system
US7229792B2 (en) Method of producing recombinant proteins
US4169761A (en) Process for the cultivation of viruses
IL44196A (en) Immobilized glucose isomerase composition
EP0225860A3 (en) A method to export gene products to the growth medium of gram negative bacteria
CA2015046C (en) Recombinant dna and expression vector
US4497730A (en) Method for obtaining periplasmic proteins from bacterial cells using chloroform
US3832284A (en) Method for manufacture of alpha-galactosidase by microorganisms
JPS61181374A (en) Production of neutral protease
US4064011A (en) Process for producing ECoRI restriction endonuclease with E.coli mutants
Janeček Synthesis of β-galactosidase in Escherichia coli in the presence of phenylalanine analogues
US5002877A (en) Production of plasminogen activator from cells to which lectin is added to the culture medium
UA26125A (en) METHOD OF ISSUE OF GROWING CELL MICROORGHISMS FROM NUTRITIONAL BULL
Neubauer et al. Process for production of ColE 1- and related plasmids.
INUKAI et al. STUDIES ON HEMOLYTIC ESCHERICHIA COLI OF O-139 A CERTAIN FACTOR ESSENTIAL FOR HEMOLYSIN PRODUCTION
CA1156166A (en) Recombinant bacterial plasmids containing the coding sequences of insulin genes
CN117886908A (en) Pear DEFL27 protein and in-vitro expression method and application thereof

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)